Publications by authors named "Yusuke Onozawa"

Claim this Profile
M
Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Satoshi Suzuki, Tomoya Yokota, Akifumi Notsu, Satoshi Hamauchi, Kunihiro Fushiki, Yusuke Onozawa

Int J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal number of needle passes in EUS-guided tissue sampling for genomic profiling: a randomized, noncomparative trial.
Hirotoshi Ishiwatari, Kazuma Ishikawa, Junya Sato, Fumitaka Niiya, Hirofumi Yasui, Yusuke Onozawa

Gastrointest Endosc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.
Satoshi Hamauchi, Hirofumi Yasui, Tomoya Yokota, Takahiro Tsushima, Kunihiro Fushiki, Yusuke Onozawa

Invest New Drugs· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.
Satoshi Suzuki, Tomoya Yokota, Akifumi Notsu, Satoshi Hamauchi, Yusuke Onozawa

Oncologist· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008.
Hidetoshi Shimizu, Takeshi Kodaira, Naomi Kiyota, Ryuichi Hayashi, Hiroshi Nishino, Yusuke Onozawa

Oral Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.
Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Yusuke Onozawa

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.
Ari Nishimura, Satoshi Hamauchi, Akifumi Notsu, Kunihiro Fushiki, Kotoe Oshima, Yusuke Onozawa

BMC Palliat Care· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.
Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Yusuke Onozawa

Oral Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-induced xerostomia and cariogenic dietary habits.
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Yusuke Onozawa

Support Care Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
Hiroya Taniguchi, Kentaro Yamazaki, Toshiki Masuishi, Takeshi Kawakami, Yusuke Onozawa

Oncologist· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique case of giant mushroom-like gastric tumor: metastasis from inferior vena cava leiomyosarcoma.
Tatsunori Minamide, Yusuke Onozawa, Hiroyuki Ono

Gastrointest Endosc· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEDI0457 Plus Durvalumab in HPV-associated HNSCC-Letter.
Keita Mori, Akifumi Notsu, Keita Miura, Yusuke Onozawa

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin.
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Yusuke Onozawa

BMC Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study.
Sae Ohwada, Akiko Todaka, Hiroshi Nakase, Hiromichi Shirasu, Takeshi Kawakami, Yusuke Onozawa

Invest New Drugs· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Akifumi Notsu

BMC Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence.
Kazuaki Yasui, Ryota Kondou, Haruo Miyata, Akira Iizuka, Tadashi Ashizawa, Yusuke Onozawa

Anticancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.
Naomi Kiyota, Makoto Tahara, Junki Mizusawa, Takeshi Kodaira, Hirofumi Fujii, Yusuke Onozawa

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer.
Hiroto Inoue, Akiko Todaka, Kentaro Yamazaki, Kunihiro Fushiki, Hiromichi Shirasu, Yusuke Onozawa

Invest New Drugs· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Hiromichi Shirasu

Int J Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplemental enteral tube feeding nutrition after hospital discharge of esophageal cancer patients who have undergone esophagectomy.
Masahiro Niihara, Yasuhiro Tsubosa, Aiko Yamashita, Keita Mori, Hiromi Tsumaki, Yusuke Onozawa

Esophagus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful?
Tomoya Yokota, Tetsuro Onitsuka, Satoshi Hamauchi, Hiromichi Shirasu, Yusuke Onozawa

Int J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
Hidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami, Kohei Akiyoshi, Yoshihiko Segawa, Yusuke Onozawa

JAMA Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.
Hiromichi Shirasu, Tomoya Yokota, Takeshi Kawakami, Satoshi Hamauchi, Yusuke Onozawa

Int J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and efficacy of chemoradiotherapy with concurrent split-dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for locally advanced head and neck cancer.
Tomoya Yokota, Masayuki Shibata, Satoshi Hamauchi, Hiromichi Shirasu, Yusuke Onozawa

Mol Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Should We Approach Locally Advanced Squamous Cell Carcinoma of Head and Neck Cancer Patients Ineligible for Standard Non-surgical Treatment?
Tomoya Yokota, Satoshi Hamauchi, Hiromichi Shirasu, Yusuke Onozawa, Hirofumi Ogawa

Curr Oncol Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis